Replies to post #20130 on Bioelectronics Corp (BIEL)

[Simpsonly]

Then, let's say there's as little as a 50/50 chance BIEL will get FDA approvals on ActiPatch and ALLAY for women's menstrual issues - I happen to think it's much higher given the existing approval on its' RecoveryRx. If the company didn't already have that FDA approval, that would make it a small newbie applicant, which would probably mean a much smaller chance of approval, but the technology and products are well known, studied and approved by the FDA. Am I missing something here?

Wouldn't the time to acquire a large stock position quietly be now, if you are a senior officer of one of the large pain medication companies like Gorsky at J&J, who already knows devices? He]], you could chip away at this thing daily, pick up 100 million shares for less than $250K, probably J&J's postage for a couple of days, while the FDA does its thing and then smile at 25 cents or better, as some suggest, having just made your company about $25million. Or, looking at it another way, you would have picked up a big piece of an approved chemical and drug-free painkiller device company for a quarter of a million to then take it forward. Wish I had deep pockets.